Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome.

Zimbron J, Khandaker GM, Toschi C, Jones PB, Fernandez-Egea E.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1353-65. doi: 10.1016/j.euroneuro.2016.07.010.

PMID:
27496573
2.

The 'Old' Anti-Diabetic Agents: A Systematic Inventory.

Buhse S, Mühlhauser I, Lenz M.

Endocr Dev. 2016;31:28-42. doi: 10.1159/000439369. Review.

PMID:
26824239
3.

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.

Pladevall M, Riera-Guardia N, Margulis AV, Varas-Lorenzo C, Calingaert B, Perez-Gutthann S.

BMC Cardiovasc Disord. 2016 Jan 15;16:14. doi: 10.1186/s12872-016-0187-5.

4.

The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis.

Billington EO, Grey A, Bolland MJ.

Diabetologia. 2015 Oct;58(10):2238-46. doi: 10.1007/s00125-015-3660-2. Review.

PMID:
26109213
5.

Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis.

Mearns ES, Saulsberry WJ, White CM, Kohn CG, Lemieux S, Sihabout A, Salamucha I, Coleman CI.

Diabet Med. 2015 Dec;32(12):1530-40. doi: 10.1111/dme.12837.

PMID:
26104021
6.

Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.

Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, Davies M, Goyder E.

Diabetes Res Clin Pract. 2015 Mar;107(3):320-31. doi: 10.1016/j.diabres.2015.01.027. Review.

PMID:
25638454
7.

The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies.

Varas-Lorenzo C, Margulis AV, Pladevall M, Riera-Guardia N, Calingaert B, Hazell L, Romio S, Perez-Gutthann S.

BMC Cardiovasc Disord. 2014 Sep 26;14:129. doi: 10.1186/1471-2261-14-129. Review.

8.

Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis.

Zintzaras E, Miligkos M, Ziakas P, Balk EM, Mademtzoglou D, Doxani C, Mprotsis T, Gowri R, Xanthopoulou P, Mpoulimari I, Kokkali C, Dimoulou G, Rodopolou P, Stefanidis I, Kent DM, Hadjigeorgiou GM.

Clin Ther. 2014 Oct 1;36(10):1443-53.e9. doi: 10.1016/j.clinthera.2014.06.035.

PMID:
25109773
9.

Vitamin B12 status in metformin treated patients: systematic review.

Liu Q, Li S, Quan H, Li J.

PLoS One. 2014 Jun 24;9(6):e100379. doi: 10.1371/journal.pone.0100379. Review.

10.

Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.

Mizuno Y, Suzuki T, Nakagawa A, Yoshida K, Mimura M, Fleischhacker WW, Uchida H.

Schizophr Bull. 2014 Nov;40(6):1385-403. doi: 10.1093/schbul/sbu030. Review.

11.

Systematic reviews to ascertain the safety of diabetes medications.

Gionfriddo MR, Morey-Vargas OL, Brito JP, Leppin AL, Murad MH, Montori VM.

Curr Diab Rep. 2014 Apr;14(4):478. doi: 10.1007/s11892-014-0478-0. Review.

12.

The pharmacogenetics of type 2 diabetes: a systematic review.

Maruthur NM, Gribble MO, Bennett WL, Bolen S, Wilson LM, Balakrishnan P, Sahu A, Bass E, Kao WH, Clark JM.

Diabetes Care. 2014;37(3):876-86. doi: 10.2337/dc13-1276. Review.

13.

Three decades after Gjönnaess's laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach.

Abu Hashim H, Al-Inany H, De Vos M, Tournaye H.

Arch Gynecol Obstet. 2013 Aug;288(2):409-22. doi: 10.1007/s00404-013-2808-x. Review.

PMID:
23543241
14.

Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.

Dong H, Wang N, Zhao L, Lu F.

Evid Based Complement Alternat Med. 2012;2012:591654. doi: 10.1155/2012/591654.

15.

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH.

Cochrane Database Syst Rev. 2012 May 16;(5):CD003053. doi: 10.1002/14651858.CD003053.pub5. Review.

PMID:
22592687
16.

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, Sattar N, Fraser A, Waugh N.

Health Technol Assess. 2011 Nov;15(38):1-110. doi: 10.3310/hta15380. Review.

17.

The efficacy and safety of liraglutide.

Jeong KH, Yoo BK.

Int J Clin Pharm. 2011 Oct;33(5):740-9. doi: 10.1007/s11096-011-9552-8. Review.

PMID:
21952951
18.

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studies.

Marso SP, Lindsey JB, Stolker JM, House JA, Martinez Ravn G, Kennedy KF, Jensen TM, Buse JB.

Diab Vasc Dis Res. 2011 Jul;8(3):237-40. doi: 10.1177/1479164111408937.

PMID:
21653676
19.

Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report [Internet].

Jonas D, Van Scoyoc E, Gerrald K, Wines R, Amick H, Triplette M, Runge T.

Portland (OR): Oregon Health & Science University; 2011 Feb.

20.

Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis.

Singh S, Loke YK, Furberg CD.

Thorax. 2011 May;66(5):383-8. doi: 10.1136/thx.2010.152777. Review.

PMID:
21325145
Items per page

Supplemental Content

Loading ...
Support Center